Literature DB >> 27718454

Association of binge eating behavior and psychiatric comorbidity in ELSA-Brasil study: Results from baseline data.

Andréa Poyastro Pinheiro1, Maria Angélica Nunes2, Natália Bordin Barbieri2, Álvaro Vigo2, Estela L M Aquino3, Sandhi Barreto4, Dora Chor5, Maria Inês Schmidt2.   

Abstract

OBJECTIVE: To estimate the association of binge eating behavior (BE) with common mental disorders (CMD).
METHOD: Cross sectional investigation of 14,088 adults, aged 35-74years (ELSA-Brasil study). BE was assessed with Structured Clinical Interview for DSM Disorders (SCID - DSM IV) questions, and psychiatric morbidity with CIS-R (CIS R - Clinical Interview Schedule Revised). Poisson regression was used to estimate the association of BE and psychiatric morbidity.
RESULTS: Adjusted prevalence ratios (PR) for CMD and BE were: PR=1.60 (1.34-1.91) for a CIS R score 12-18 (presence of CMD with lower clinical severity); PR=2.40 (2.06-2.80) for a CIS R score≥18 (severe symptom profile likely to require treatment); for psychiatric diagnoses: PR=2.24 (1.84-2.73) for depressive episodes; PR=1.77 (1.53-2.04) for anxiety disorders, and PR=1.42 (1.20-1.67) for mixed depressive-anxiety disorder.
CONCLUSION: BE was associated with higher prevalence of common mental disorders. Our findings highlight the need to investigate mechanisms involved in the relationship of BE, obesity and psychopathology in low/middle income countries. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Binge eating disorder; Comorbidity; Eating disorders; Mental disorders

Mesh:

Year:  2016        PMID: 27718454     DOI: 10.1016/j.eatbeh.2016.08.011

Source DB:  PubMed          Journal:  Eat Behav        ISSN: 1471-0153


  1 in total

1.  Longitudinal association between binge eating and metabolic syndrome in adults: Findings from the ELSA-Brasil cohort.

Authors:  Francesca Solmi; Arlinda B Moreno; Glyn Lewis; Maria Angélica Nunes; Maria de Jesus Mendes da Fonseca; Rosane Harter Griep
Journal:  Acta Psychiatr Scand       Date:  2021-08-16       Impact factor: 7.734

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.